Orléans, France-based Overseed Biotech, which focuses on agronomic research and development of cannabis-derived medicines, raised 6.7 million euros ($7.25 million) in Series A fundraising round with the goal of becoming the first French manufacturer of 100% medical cannabis medicines, writes EU-Startups.”On the French market, we are 2 to 3 years ahead in terms of manufacturing expertise, and will be ready to offer high-quality, high-volume production from day 1,” stated Hugues Péribère,…
Read More…